The association of HLA-DRB genes and the shared epitope with rheumatoid arthritis in Pakistan by Hameed, K et al.
eCommons@AKU
Section of Internal Medicine Department of Medicine
November 1997
The association of HLA-DRB genes and the shared
epitope with rheumatoid arthritis in Pakistan
K Hameed
Aga Khan University
S Bowman
E Kondeatis
R Vaughan
T Gibson
Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_med_intern_med
Part of the Internal Medicine Commons
Recommended Citation
Hameed, K., Bowman, S., Kondeatis, E., Vaughan, R., Gibson, T. (1997). The association of HLA-DRB genes and the shared epitope
with rheumatoid arthritis in Pakistan. British Journal of Rheumatology, 36(11), 1184-1188.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_med_intern_med/98
THE ASSOCIATION OF HLA-DRB GENES AND THE SHARED EPITOPE
WITH RHEUMATOID ARTHRITIS IN PAKISTAN
K. HAMEED,* S. BOWMAN,}} E. KONDEATIS,% R. VAUGHAN% and T. GIBSON$
*Department of Medicine, Aga Khan University Hospital, Karachi, Pakistan, $Clinical Rheumatology Unit,
%Tissue Typing Laboratory and }Molecular Immunogenetics Unit, UMDS, Guy’s Hospital, London
SUMMARY
The association of particular HLA-DR alleles and the shared epitope with rheumatoid arthritis (RA) is now well established.
The strength of these links varies between races. Furthermore, the proposition that the presence of the shared epitope is
indicative of severe disease has been more dicult to sustain in non-Europeans. This study examines the frequency of
HLA-DR and HLA-DRB1 amongst Pakistanis for the first time. Using the polymerase chain reaction (PCR) and sequence-
specific oligonucleotide probes (PCR-SSOP) and primers (PCR-SSP), HLA-DR phenotype and genotype frequencies were
ascertained in 86 RA hospital out-patients and 79 healthy controls matched for age, gender and ethnicity. HLA-DR1 and
HLA-DR4 frequency was similar in patients and controls. HLA-DR10 occurred in 26 instances (15%) in RA and in eight
(5%) controls (Pcorr = 0.048). HLA-DR2 was also increased in patients (P= 0.053) and its major subtype DR15 was
significantly increased (Pcorr = 0.03). HLA-DR5 frequency was 5% in patients and 19% in controls (Pcorr = 0.002). The
HLA- DR4 alleles possessing the shared epitope were more common in RA (Pcorr = 0.03) and this dierence was enhanced
by inclusion of other alleles possessing the shared epitope (Pcorr = 0.002). Shared epitope alleles were observed in 43 (50%)
patients and 17 (22%) controls (Pcorr = 0.003). The shared epitope did not distinguish patients with more severe disease, as
reflected by pain, joint deformities, disability, rheumatoid factor or X-ray damage. The distribution of HLA-DR alleles in
Pakistanis with RA supports the shared epitope hypothesis. In common with other non-European racial groups, HLA-DR4
was not associated with RA. Unlike other groups, there was a weak link of RA with HLA-DR2. A protective eect of
HLA-DR5 was apparent. In accord with some other studies, the shared epitope in this hospital out-patient population was
not a marker for more severe disease.
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THE association of rheumatoid arthritis (RA) with
specific HLA-DR alleles in dierent racial groups has
contributed to the shared epitope hypothesis [1, 2].
The distinctive linking of RA with HLA-DRB1
alleles carrying the amino acid sequence QKRAA/
QRRAA provides unifying evidence for the genetic
contribution to RA. However, within some popula-
tions, possession of the shared epitope contributes
only slightly, if at all, toward disease susceptibility
[3]. Furthermore, there remains doubt about whether
the shared epitope is a disease susceptibility or
severity marker [4, 5]. There is some evidence that the
shared epitope on HLA-DRB1*0401 and *0404 is
associated with more serious disease in Caucasians
[6], but amongst other races this relationship is less
evident [7, 8]. In people of African and Hispanic
derivation, the association of the shared epitope with
RA is tenuous [8, 9]. Thus, although the shared
epitope hypothesis is supported by a growing body of
evidence from dierent communities, the strength of
the association with disease susceptibility or severity
is inconsistent. Understanding the relevance of
particular HLA alleles and the shared epitope to RA
disease pathogenesis might be advanced by wider
exploration of the world’s populations. We sought
to determine the association of HLA-DR specificities
and their alleles with RA and its severity amongst
Pakistanis, a national group not previously invest-
igated in this way.
PATIENTS AND METHODS
Venous blood samples were taken from 86 RA
patients attending a rheumatology clinic at the Aga
Khan University Hospital, Karachi. They all satisfied
the standard criteria for RA [10]. Clinical evaluation
was performed by a single physician using the
Stanford Health Assessment Questionnaire [11], the
Ritchie joint tenderness score [12], and a count of large
and small joint deformities. The erythrocyte sedimen-
tation rate (ESR) was measured by the Westergren
method and rheumatoid factor by a latex test. X-rays
of hands and feet were scored blind by a single
investigator using standard films for comparison [13].
Blood was also obtained from 79 healthy controls.
These were either hospital employees or visitors who
were unrelated to the patients. All subjects were of
South Asian origin, but because of the ethnic hetero-
geneity of Pakistan, controls were matched closely
for age, sex and the religious or regional aliation by
which subjects defined their ethnicity, e.g. Pathan,
Memon, Punjabi, Ismaili, etc.
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All blood samples were taken into anticoagulant
and stored at ÿ408C, and later transported to
London in dry ice. The extraction of genomic DNA,
HLR-DR genotyping and HLA-DR2 and DR4 sub-
typing were performed using previously described
methods involving polymerase chain reaction (PCR)
and sequence-specific oligonucleotide probes (PCR-
SSOP) [14, 15]. Confirmatory testing of some samples
was conducted using sequence-specific primers (PCR-
SSP) [16, 17]. The results were evaluated using w2
tests with a correction factor of 10 for the number of
HLA-DR types examined. Clinical comparisons
between patients with and without the shared epitope
were made using w2 and Mann–Whitney U-tests.
There were insucient subjects carrying HLA-DR4
to allow a similar comparison of this specificity and
its associated alleles.
RESULTS
Demographic details of the patients and controls
are shown in Table I. The distribution of HLA-DR
alleles is shown in Table II. There was no significant
dierence in the frequency of HLA-DR1 and -DR4
between patients and controls. There was a significant
reduction of HLA-DR5 amongst patients. All posi-
tive DR5 samples were HLA-DR5 [11], except in one
control where DR5 [12] was identified. Amongst RA
subjects, HLA-DR2 was found in 45 (52%) and
amongst controls in 27 (34%) (Pcorr = 0.3). The
total frequency of HLA-DR2 in RA subjects almost
reached the conventional level of significance
(P= 0.053) when the frequency was compared with
that of controls (Table II). There was a statistically
significant increase of HLA-DR10 frequency in RA
(Table II). The HLA-DR2 and -DR4 subtypes, and
the shared epitope frequencies, are shown in
Table III. The major subtype of HLA-DR2 was
DR15 and this was significantly more frequent in RA
(P= 0.03), but no dierence was apparent for the
separate DR2 alleles, DR2*1501, *1502, *1601/2.
Similarly, the HLA-DR4 alleles were not significantly
dierent in frequency, although it is noteworthy that
DR4 alleles possessing the shared epitope (*0401,
*0404, *0405/8) were more common in RA and the
sum of their frequencies was significantly greater
(Pcorr = 0.03). This significance was enhanced by
the inclusion of the other shared epitope alleles
*0101/2, *1402 and *1001 (Pcorr = 0.002). Shared
epitope alleles were observed in 43 (50%) RA
patients and 17 (22%) controls (Pcorr = 0.003).
Homozygosity for the shared epitope was observed in
10 RA patients and in three controls (NS).
Comparison of RA patients with and without the
shared epitope did not reveal any dierence in disease
activity or severity, the latter being measured by the
number of joint deformities, a disability score and
X-ray damage (Table IV). The two groups were
similar in sex distribution, age and disease duration.
Disease-modifying anti-rheumatic drug (DMARD)
use was increased in those with the shared epitope,
but not significantly.
The RA population in Pakistan has a higher fre-
quency of rheumatoid factor positivity than white
Caucasians [18]. Those with the shared epitope had a
TABLE I
The gender, age and ethnic distribution of RA patients and their
controls. Ethnicity was determined by subjects with reference to
their language, branch of the Muslim faith or the places of origin
of their families in the South Asian subcontinent
RA patients
(n= 86)
Healthy controls
(n= 79)
Gender 28 M 58 F 25 M 54 F
Median age (range) 44 (18–81) 45 (24–80)
Ethnicity
No. (%) No. (%)
North Indian 33 (38) 33 (42)
South Indian 3.0 (3.5) –
Central Indian 3.0 (3.5) –
Punjabi 17 (20) 16 (20)
Sindhi 4.0 (5.0) 2.0 (2.0)
Pathan 7.0 (8.0) 6.0 (8.0)
Bengali 1.0 (1.0) –
Baluch 1.0 (1.0) 1.0 (1.0)
Memon 10 (12) 11 (14)
Ismaili 7.0 (8.0) 10 (13)
Total 86 79
TABLE II
HLA-DR phenotype frequency among 86 RA patients and 79 healthy controls
HLA-DR
RA
[no. (%)]
Controls
[no. (%)]
Odds ratio
(95% CI)
Significance
(corrected)
1* 5 (2.9) 8 (5.1) 0.55 (0.18, 1.67) NS
2 57 (33.1) 30 (19.0) 3.21 (1.70, 6.06) P= 0.053
3 23 (13.4) 28 (17.7) 0.66 (0.34, 1.29) NS
4 23 (13.4) 12 (7.6) 2.04 (0.95, 4.39) NS
5$ 9 (5.2) 30 (19.0) 0.19 (0.09, 0.43) P= 0.002
6 12 (7.0) 19 (12.0) 0.51 (0.23, 1.13) NS
7 13 (7.6) 20 (12.7) 0.53 (0.24, 1.13) NS
8 1 (0.6) 0 (0) – NS
9 3 (1.7) 3 (1.9) 0.92 (0.21, 4.09) NS
10 26 (15.1) 8 (5.1) 3.85 (1.65, 8.95) P= 0.048
*All DRB1*0101, except for one control who was *0102.
$All DR5 [11], except for one control who was DR5 [12].
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higher prevalence of positive RA latex tests, but this
did not reach statistical significance (w2=2.71;
P= 0.09).
The 10 patients who were homozygous for the
shared epitope did not exhibit more severe disease
measurements than those who were heterozygous.
Similarly, those with HLA-DR2 had similar age, sex,
disease duration and DMARD use to those without
HLA-DR2, and the indices of disease activity and
severity were not significantly dierent between them
(data not shown).
DISCUSSION
RA is a ubiquitous disorder, although in urban
Pakistan and amongst Pakistanis living in England
the prevalence seems to be less than amongst white
Caucasians [19, 20]. We have speculated that this
apparent reduced susceptibility may be genetic. The
available evidence indicates that the frequency with
which the shared epitope occurs is roughly propor-
tional to the estimates of disease prevalence [21]. For
example, the striking frequency of the allele HLA-
DRB1*1402 amongst Tlingit Indians with RA, and
amongst the healthy Tlingit, probably contributes to
the high prevalence of RA in this population [7]. By
contrast, the prevalence of the shared epitope in
Singaporean Chinese with RA and their controls is
similar to that reported by us amongst Pakistanis
TABLE III
HLA-DR genotype frequency among 86 RA patients and 79 healthy controls
HLA-DR
RA
[no. (%)]
Controls
[no. (%)]
Odds ratio
(95% CI)
Significance
(corrected)
HLA-DR2
*1501 28 (16) 12 (7.0) 2.7 (1.27, 5.71) NS
*1502 24 (14) 13 (8.0) 1.97 (0.93, 4.15) NS
*1601/2 5 (3.0) 5 (3.0) 0.91 (0.27, 3.08) NS
HLA-DR4
*0401 5 (3.0) 1 (0.5) 4.81 (0.55, 42.14) NS
*0404 7 (4.0) 1 (0.5) 6.91 (1.07, 30.8) NS
*0405 4 (2.0) 2 (1.0) 1.88 (0.33, 10.55) NS
*0408 3 (2.0) 0 – NS
*0405/08 1 (1.0) 0 – NS
*0401/4/5/8 20 (12) 4 (2.0) 5.68 (1.92, 16.65) P= 0.03
*0402 2 (1.0) 2 (1.0) 0.92 (0.16, 5.33) NS
*0403 1 (0.5) 6 (4.0) 0.14 (0, 0.94) NS
Shared epitope* 52 (30) 20 (13) 4.51 (2.33, 8.75) P= 0.002
No. with shared
epitope homozygosity
*0401/*0404 1 0
*0404/*0404 1 0
*0405/*0405/8 1 0
*0401/*1001 1 0
*0405/*1001 1 0
*1001/*1001 5 0
*0101/*0101 0 2
*0101/*1001 0 1
Total (%) 10 (12) 3 (4.0) 3.33 (0.95, 11.64) NS
*Shared epitope alleles in this analysis were *0101/2, *0401/4/5/8, *1402, *1001.
TABLE IV
Details of RA patients who did or did not possess the shared epitope. Results are expressed as median (range) or no. (%). Statistical signific-
ance was sought by w2 or Mann–Whitney U-tests
Shared epitope
Positive Negative Significance
Males 15 (35%) 13 (30%) NS
Females 28 (65%) 30 (70%) NS
Age (yr) 44 (23–81) 43 (18–72) NS
Disease duration (yr) 5.0 (1.0–28) 7.0 (1.0–42) NS
DMARD 32 (74%) 29 (67%) NS
Ritchie index 9.0 (0–25) 8.0 (0–33) NS
No. of deformities 5.0 (0–24) 5.0 (0–24) NS
HAQ (raw scores) 12 (0–52) 10 (0–58) NS
ESR (mm/h) 56 (6–128) 55 (12–130) NS
Rheumatoid factor (latex positive) 39 (91%) 34 (81%) NS
X-ray score 8.2 (0–67) 9.0 (0–55) NS
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[22]. The prevalence of RA amongst neighbouring
Hong Kong Chinese is relatively low, as it is in
Pakistan [23]. However, amongst the Chinese of
urban Taiwan, the shared epitope frequency amongst
RA patients and controls is similar to that of the
West, and the prevalence of the disease in this popula-
tion is similar to that of white Caucasians [24, 25].
The importance of the shared epitope to the genetic
contribution of RA susceptibility is further empha-
sized by monozygotic twins in whom concordance for
RA is rare in the absence of the epitope [26].
However, concordance for RA is a feature in <25%
of identical twins, indicating that although inheritance
is important to susceptibility, it does not account
entirely for disease determination [27]. Furthermore,
the shared epitope appears less relevant to disease sus-
ceptibility in some non-white racial groups, such as
North Americans of Hispanic [7] and African descent
[8]. Even amongst white Caucasians in southern
Europe, evidence for the hypothesis is less strong [28].
Surveys of RA patients of South Asian derivation
indicate marked genetic heterogeneity. Without
exception, these studies have been consistent with
the shared epitope hypothesis. However, amongst
Indians living in the West, RA is associated pre-
dominantly with the HLA-DR1 or -DR10 specificities
[29, 30], but in North India, it is with HLA-DR4 and
the allele HLA-DRB1*0405 more specifically [31].
Amongst South Asian people living in South Africa,
haplotype associations are strongest with HLA-DR4
amongst Muslims, and with HLA-DR10 amongst
Tamils and Hindus [32]. Interestingly, this study also
revealed a weak relationship with HLA-DR2
amongst the Hindu and Tamil groups, but not the
Muslims. The association of HLA-DR2 with RA in
our Pakistani population accords with this earlier
observation. There is no clear ethnic link between
Pakistanis and the two populations in South Africa.
Furthermore, in common with findings elsewhere,
HLA-DR2 frequency was found to be significantly
reduced in North Indian RA patients [31]. The
relevance of the association with HLA-DR2 in our
patients was not furthered by our exploring its
possible role as a disease severity marker. The
disparate observations relating to this specificity are
of interest, but at present cannot be explained. Our
finding of a significantly lower distribution of HLA-
DR5 in Pakistani RA patients has not been observed
in other South Asian studies. It suggests a protective
role in this population.
The possibility that the shared epitope is a determin-
ant of more severe disease rather than susceptibility is
supported by studies of early cases and the course of
their illness [6, 33]. However, in both the community
setting and in hospital, there are conflicting data
[4, 5]. It is argued that an association of the HLA-
DRB1*0401/0404 alleles with severity in men is
related to the higher threshold of males for severe,
progressive RA [34]. A view has been propagated that
amongst Caucasians, at least, there is clinical value in
the predictive potential of patient genotyping [35].
Our own study of hospital RA patients failed to
demonstrate any dierence of severity between those
with and without the shared epitope. The established
nature of the disease in these cases could have
militated against our demonstrating such an eect.
This criticism applies equally to other hospital-based
studies. It is possible that in non-Caucasians, the rela-
tionship is less apparent. It is noteworthy that
Pakistanis have less severe erosive disease than white
Caucasians and it is X-ray damage which has been
most convincingly linked with the shared epitope
[6, 33]. The relative paucity of shared epitope
frequency in Pakistanis could account for this
observation despite the failure to demonstrate any
epitope-related characteristics in the RA study
population of the current study.
The mode of influence of HLA-DR genes on RA
disease evolution is unknown. Evidence that there is
a functional association with the T-cell receptor or
tumour necrosis factor are amongst the latest pro-
posals [36, 37]. Whatever the mechanism, more infor-
mation is yet to be gleaned from studies such as ours
in other communities. The incomplete and variable
association of the shared epitope with RA in dierent
races may indicate that RA has miscellaneous envir-
onmental causes dependent on geographical location
and the presence of appropriate HLA and non-HLA
genotypes [38].
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